Amalgamated Bank Corcept Therapeutics Inc Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

A detailed history of Amalgamated Bank transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Amalgamated Bank holds 26,168 shares of CORT stock, worth $1.81 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,168
Previous 26,945 2.88%
Holding current value
$1.81 Million
Previous $1.36 Million 120.1%
% of portfolio
0.03%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
SELL
$49.85 - $114.22 $38,733 - $88,748
-777 Reduced 2.88%
26,168 $2.99 Million
Q4 2024

Feb 04, 2025
SELL
$44.66 - $60.85 $3,751 - $5,111
-84 Reduced 0.31%
26,945 $1.36 Million
Q3 2024

Oct 30, 2024
SELL
$29.51 - $46.26 $17,883 - $28,033
-606 Reduced 2.19%
27,029 $1.25 Million
Q2 2024

Aug 12, 2024
SELL
$22.21 - $34.48 $13,925 - $21,618
-627 Reduced 2.22%
27,635 $898,000
Q1 2024

Apr 23, 2024
SELL
$21.1 - $27.46 $187,283 - $243,734
-8,876 Reduced 23.9%
28,262 $712,000
Q4 2023

Feb 06, 2024
SELL
$24.82 - $32.88 $34,226 - $45,341
-1,379 Reduced 3.58%
37,138 $1.21 Million
Q3 2023

Nov 08, 2023
SELL
$21.97 - $33.8 $31,614 - $48,638
-1,439 Reduced 3.6%
38,517 $1.05 Million
Q2 2023

Aug 11, 2023
SELL
$21.44 - $25.15 $52,270 - $61,315
-2,438 Reduced 5.75%
39,956 $889,000
Q1 2023

May 02, 2023
SELL
$19.2 - $24.47 $51,724 - $65,922
-2,694 Reduced 5.97%
42,394 $918,000
Q4 2022

Feb 10, 2023
SELL
$19.95 - $29.96 $1,635 - $2,456
-82 Reduced 0.18%
45,088 $916,000
Q3 2022

Nov 09, 2022
BUY
$24.7 - $29.12 $20,525 - $24,198
831 Added 1.87%
45,170 $1.16 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $20,674 - $30,182
-1,193 Reduced 2.62%
44,339 $1.05 Million
Q1 2022

Jun 30, 2022
SELL
$16.53 - $25.21 $64,516 - $98,394
-3,903 Reduced 7.9%
45,532 $1.03 Million
Q4 2021

Feb 15, 2022
SELL
$17.1 - $23.34 $76,437 - $104,329
-4,470 Reduced 8.29%
49,435 $979,000
Q3 2021

Oct 29, 2021
SELL
$19.68 - $22.53 $19,502 - $22,327
-991 Reduced 1.81%
53,905 $1.06 Million
Q2 2021

Aug 16, 2021
BUY
$19.97 - $24.43 $801,495 - $980,498
40,135 Added 271.9%
54,896 $1.21 Million
Q1 2021

May 13, 2021
SELL
$23.49 - $30.56 $31,547 - $41,042
-1,343 Reduced 8.34%
14,761 $351,000
Q4 2020

Feb 12, 2021
BUY
$16.78 - $27.3 $5,889 - $9,582
351 Added 2.23%
16,104 $421,000
Q3 2020

Oct 30, 2020
SELL
$12.46 - $19.98 $6,441 - $10,329
-517 Reduced 3.18%
15,753 $274,000
Q2 2020

Aug 10, 2020
SELL
$11.0 - $18.26 $19,316 - $32,064
-1,756 Reduced 9.74%
16,270 $274,000
Q1 2020

May 13, 2020
SELL
$10.11 - $14.04 $7,986 - $11,091
-790 Reduced 4.2%
18,026 $214,000
Q4 2019

Feb 13, 2020
BUY
$12.06 - $16.96 $7,043 - $9,904
584 Added 3.2%
18,816 $228,000
Q3 2019

Nov 13, 2019
SELL
$10.41 - $14.66 $1,925 - $2,712
-185 Reduced 1.0%
18,232 $258,000
Q2 2019

Aug 14, 2019
BUY
$9.78 - $12.76 $21,975 - $28,671
2,247 Added 13.9%
18,417 $205,000
Q1 2019

May 15, 2019
BUY
$10.03 - $15.71 $2,768 - $4,335
276 Added 1.74%
16,170 $190,000
Q4 2018

Feb 15, 2019
BUY
$11.29 - $17.19 $179,443 - $273,217
15,894 New
15,894 $212,000
Q3 2018

Nov 14, 2018
SELL
$12.27 - $15.65 $194,393 - $247,942
-15,843 Closed
0 $0
Q2 2018

Jul 18, 2018
BUY
$15.3 - $19.69 $40,743 - $52,434
2,663 Added 20.2%
15,843 $249,000
Q1 2018

May 22, 2018
SELL
$14.59 - $25.5 $3,093 - $5,406
-212 Reduced 1.58%
13,180 $217,000
Q4 2017

Feb 13, 2018
BUY
$15.77 - $20.72 $28,591 - $37,565
1,813 Added 15.66%
13,392 $242,000
Q3 2017

Nov 09, 2017
BUY
$12.3 - $19.3 $142,421 - $223,474
11,579
11,579 $223,000

Others Institutions Holding CORT

# of Institutions
477
Shares Held
84M
Call Options Held
1.43M
Put Options Held
2.75M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.39B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email